BioXcel Therapeutics Showcases Data on BXCL701 in Combination with OX40 Agonist in Late-breaking Poster Presentation at AACR Annual Meeting
Stock Information for BioXcel Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.